Best Growth Stocks to Buy for August 28th
SNDR, NESR and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 28th, 2026.
OSCR - Oscar Health, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$27.25
DETAILS
HIGH:
$39.00
LOW:
$16.00
MEDIAN:
$28.50
CONSENSUS:
$27.25
DOWNSIDE:
10.57%
Stock News
Best Growth Stocks to Buy for August 26th
SNDR, NESR and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 26th, 2026.
As Health Insurers Gain Handle On Costs, Stocks Are Soaring Again
Following a parade of health insurance company earnings reports this summer, stocks are rising and costs appear to be under control for now.
Fast-paced Momentum Stock Oscar Health (OSCR) Is Still Trading at a Bargain
Oscar Health (OSCR) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Best Growth Stocks to Buy for August 24th
SNDR, NESR and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 24th, 2026.
Best Growth Stocks to Buy for August 20th
SNDR, NESR and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 20th, 2026.
Oscar Health Stock Analysis: Buy or Sell?
Oscar Health (OSCR -0.86%) has incorporated AI to enhance operations.
Best Growth Stocks to Buy for August 14th
MTCH, PBI, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 14, 2026.
Is Oscar Health Inc (OSCR) Overvalued After 4.0% Rally? GF Value Says Overvalued
On August 13, 2026, Oscar Health Inc (OSCR) shares rose 4.0% to a current price of $30.78, amidst a 52-week range of $10.69 to $33.10. This recent uptick follow
Best Growth Stocks to Buy for August 12th
MTCH, PBI, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 12, 2026.
Oscar Health Q2 Earnings Call Highlights
Oscar Health NYSE: OSCR reported record profitability for the first half of 2026 and raised its full-year operating outlook, citing membership growth, disciplined pricing, favorable utilization trends and lower administrative expense ratios.
GoodRx and Oscar Health Tout Tech as Consumer Needs Change
The latest earnings from Oscar Health and GoodRx show both companies dealing with a changing customer base. The former company reported half-year earnings Thursday (Aug. 6) showing record profitability for the first six months of 2026, with revenues surging 70% to $4.9 billion.
Oscar Health, Inc. (OSCR) Q2 2026 Earnings Call Transcript
Oscar Health, Inc. (OSCR) Q2 2026 Earnings Call Transcript
Oscar Health (OSCR) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Oscar Health (OSCR) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Oscar Health, Inc. (OSCR) Q2 Earnings Beat Estimates
Oscar Health, Inc. (OSCR) came out with quarterly earnings of $1.1 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to a loss of $0.89 per share a year ago.
Oscar Health Reports Another Big Profit As Obamacare Member Costs Ease
Health insurer Oscar Health swung to a $361 million second quarter profit while eclipsing $1 billion in net income for the first six months of the year as health plan membership rose and medical costs eased.
Oscar Health Announces Record Financial Results for First Half 2026 and Raises Full Year 2026 Outlook
NEW YORK--(BUSINESS WIRE)--Oscar Health announces strong 2Q 2026 results with significant year-over-year improvement across all core metrics.
Best Growth Stocks to Buy for August 6th
SANM, OSCR and PENN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 6th, 2026.
Oscar Health, Inc. (OSCR) Reports Next Week: Wall Street Expects Earnings Growth
Oscar Health (OSCR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Oscar Health, Inc. (OSCR) Dipped More Than Broader Market Today
In the latest trading session, Oscar Health, Inc. (OSCR) closed at $30.57, marking a -2.64% move from the previous day.
Price Targets
Oscar Health price target raised to $30 from $22 at Goldman Sachs
$30.00
(was $27.97)
Goldman Sachs
Oscar Health price target raised to $27 from $19 at Baird
$27.00
(was $26.57)
Robert W. Baird
Oscar Health price target raised to $39 from $35 at Barclays
$39.00
(was $26.75)
Andrew Mok
·
Barclays
Oscar Health price target raised to $36 from $26 at Piper Sandler
$36.00
(was $31.23)
Piper Sandler
Raymond James on Court Ruling: 'This should be viewed as a positive OSCR and other ACA exchange players as this puts to bed the $5 rule'
$30.00
(was $28.13)
John Ransom
·
Raymond James
Barclays Upgrades Oscar Health Inc (OSCR) to Overweight, 'we see a visible path to an undemanding 13–15x P/E valuation'
$35.00
(was $27.22)
Andrew Mok
·
Barclays
Wells Fargo Upgrades Oscar Health Inc (OSCR) to Equal Weight
$20.00
(was $20.50)
Stephen Baxter
·
Wells Fargo
Oscar Health price target raised to $30 from $21 at Barclays
$30.00
(was $21.70)
Barclays
Oscar Health price target raised to $20 from $15 at UBS
$20.00
(was $19.84)
Jonathan Yong
·
UBS
Oscar Health price target raised to $21 from $18 at Barclays
$21.00
(was $19.84)
Barclays
Oscar Health upgraded to Hold from Underperform at Jefferies
$16.00
(was $15.79)
David Windley
·
Jefferies
Oscar Health upgraded to Outperform from Market Perform at Raymond James
$18.00
(was $13.60)
Raymond James
Oscar Health price target lowered to $15 from $17 at UBS
$15.00
(was $13.56)
Jonathan Yong
·
UBS
Oscar Health upgraded to Neutral from Sell at UBS
$17.00
(was $16.90)
UBS
Oscar Health upgraded to Equal Weight from Underweight at Barclays
$18.00
(was $14.97)
Andrew Mok
·
Barclays
Oscar Health initiated with a Neutral at Goldman Sachs
$17.00
(was $20.40)
Goldman Sachs
Oscar Health price target raised to $14 from $10 at Wells Fargo
$14.00
(was $22.31)
Wells Fargo
Oscar Health price target lowered to $13 from $14 at Piper Sandler
$13.00
(was $14.64)
Jessica Tassan
·
Piper Sandler
Oscar Health Inc (OSCR) PT Raised to $28 at Piper Sandler
$28.00
(was $18.38)
Jessica Tassan
·
Piper Sandler
Piper Sandler Starts Oscar Health Inc (OSCR) at Overweight
$25.00
(was $17.64)
Jessica Tassan
·
Piper Sandler